Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biprojet Pharma is a French pharmaceutical company specializing in the development, marketing, and distribution of generic medicines. Founded in 2004 and headquartered in Boulogne-Billancourt, the company focuses on providing high-quality, affordable healthcare solutions to the French market. Its portfolio encompasses a wide range of therapeutic areas, including pain management, cardiology, and infectious diseases, with a strong presence in retail pharmacies. Biprojet operates as a Laboratoire Exploitant, ensuring compliance with rigorous French and European regulatory standards for drug safety and efficacy. By offering cost-effective alternatives to brand-name medications, the company plays a vital role in supporting the sustainability of the national healthcare system. Biprojet maintains a lean operational structure while collaborating closely with manufacturing partners to deliver essential treatments to patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biprojet.